Gao, Q., Dong, X., Xu, Q., Zhu, L., Wang, F., Hou, Y., & Chao, C. (2019). Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy. Cancer Med.
Chicago Style aipamenaGao, Qianqian, Xuan Dong, Qumiao Xu, Linnan Zhu, Fei Wang, Yong Hou, and Cheng‐chi Chao. "Therapeutic Potential of CRISPR/Cas9 Gene Editing in Engineered T‐cell Therapy." Cancer Med 2019.
MLA aipamenaGao, Qianqian, et al. "Therapeutic Potential of CRISPR/Cas9 Gene Editing in Engineered T‐cell Therapy." Cancer Med 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.